dr. heinemann on the use of depth of response and recist in crc
Published 7 years ago • 195 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
1:28
dr. heinemann on implications of sirflox study for mcrc
-
8:11
how accurate is recist 1.1 for assessing tumor response?
-
7:51
imaging 101: response criteria
-
43:39
merit webinar: recist 1.1 & oncology trial endpoints
-
8:44
basics of oncologic staging and restaging / recist
-
0:54
response evaluation criteria in solid tumors (recist)
-
2:37
tumor sidedness and treatment considerations in mcrc
-
10:20
imaging 101: immunotherapy criteria
-
43:40
고형암 임상시험에서 recist 1.1과 irecist 수행방법
-
9:36
imaging 101: recist 1 1 criteria
-
49:31
response evaluation criteria in solid tumors (recorded live)
-
1:20:07
ct in oncology - assessment of tumor response, recist and its challenges
-
7:16
irecist and immunotherapy application in the follow up of patients
-
1:41
recist and irecist criteria for the evaluation of nivolumab ipilimumab in msi/dmmr mcrc
-
2:29
measuring therapeutic response in colon cancer
-
10:20
should recist-pd lead to a change of treatment? laure fournier, m.d.
-
10:06
understanding tumor sidedness in colorectal cancer
-
4:38
everolimus and sunitinib in pancreatic neuroendocrine tumors
-
8:35
renal tumors case 6
-
16:41
the surge of male mortality
-
28:27
russell zwiener, md, case study c type iv choledochal cyst and type iii in the setting of acute recu
-
6:07
complexities in diagnosing neuroendocrine tumors